Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCOT trial
NL-OMON36249Phase 4Active, not recruiting
- Sponsor
- University of Dundee
- Start
- Jun 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of celecoxib in osteoarthritis (OA) and rheumatoid arthritis (RA) (2 arms), sponsored by University of Dundee. Started Jun 2011; status: active, not recruiting.
02
Drugs
celecoxib
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON36249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON36249.